Taking Cancer On Webinar – Let’s TOAST to Maximising Time on EGFR-TKI Therapy (Lecture)

Taking Cancer On Webinar – Let’s TOAST to Maximising Time on EGFR-TKI Therapy (Lecture)

Speaker: Prof. Jin-Hyoung Kang

Document ID: PC-MY-102220

Watch Prof. Jin-Hyoung Kang as he discusses how sequential approach with upfront GIOTRIF® (afatinib) is a feasible and cost-effective treatment strategy for EGFR M+ NSCLC patients.

Speaker

Prof. Jin-Hyoung Kang

Professor of Medicine, Seoul St. Mary’s Hospital
Director in Medical Oncology Program, The Catholic University of Korea
Seoul, South Korea

Taking Cancer On Webinar – Let’s TOAST to Maximising Time on EGFR-TKI Therapy (Q&A)

Speaker: Prof. Jin-Hyoung Kang

Uncovering the Uncommon: Efficacy of Afatinib in Uncommon and Compound Mutations

Speaker: Dr. Cheah Soon Keat